Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natures Sunshine Products (NATR) Cash & Equivalents (2016 - 2025)

Natures Sunshine Products (NATR) has disclosed Cash & Equivalents for 16 consecutive years, with $93.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 10.85% to $93.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $93.9 million, a 10.85% increase, with the full-year FY2025 number at $93.9 million, up 10.85% from a year prior.
  • Cash & Equivalents was $93.9 million for Q4 2025 at Natures Sunshine Products, down from $95.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $95.6 million in Q3 2025 to a low of $56.3 million in Q2 2022.
  • A 5-year average of $76.4 million and a median of $76.9 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: soared 42.26% in 2021, then crashed 30.34% in 2022.
  • Natures Sunshine Products' Cash & Equivalents stood at $86.2 million in 2021, then plummeted by 30.34% to $60.0 million in 2022, then soared by 37.22% to $82.4 million in 2023, then grew by 2.82% to $84.7 million in 2024, then increased by 10.85% to $93.9 million in 2025.
  • Per Business Quant, the three most recent readings for NATR's Cash & Equivalents are $93.9 million (Q4 2025), $95.6 million (Q3 2025), and $81.3 million (Q2 2025).